A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Conditions:   Lymphoblastic Lymphoma;   T-Cell Lymphoblastic Leukemia/Lymphoma;   Lymphoblastic Leukemia Intervention:   Biological: BEAM-201 Sponsor:   Beam Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials